Search Within

Nancy T Sklarin

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (7)
Groups
  1. Breast Medicine Service (16)
  2. Department of Medicine (16)
  3. Population Sciences Research Program (16)
  4. Solid Tumor Oncology Division (16)
  5. Survivorship Research (15)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (14)

More Groups

People
  1. Clifford Hudis (14)
  2. Gabriella D'Andrea-Carlino (12)
  3. Larry Norton (12)
  4. Monica Fornier (12)
  5. Chau Dang (10)
  6. Teresa Gilewski (10)

More People

Years
  1. 2016 (1)
  2. 2015 (1)
  3. 2013 (1)
  4. 2012 (3)
  5. 2011 (1)
  6. 2008 (1)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Breast Cancer Research and Treatment (4)
  3. Cancer Research (2)
  4. Clinical Cancer Research (2)
  5. Cancer Investigation (1)
Publishers
  1. American Society of Clinical Oncology (7)
  2. American Association for Cancer Research (4)
  3. Springer (4)
  4. Informa Healthcare (1)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Preliminary cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Arterial desaturation syndrome following pleurodesis with talc slurry: Incidence, clinical features, and outcome
    Journal Article

    Bondoc, A. Y.; Bach, P. B.; Sklarin, N. T.; Vander Els, N. J.
    Cancer Investigation (2003)

    Fulltext@MSK | Save
  • Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
    Journal Article

    Seidman, A. D.; Fornier, M. N.; Esteva, F. J.; Tan, L.; Kaptain, S.; Bach, A.; Panageas, K. S.; Arroyo, C.; Valero, V.; Currie, V.; more...
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma
    Journal Article

    Fornier, M. N.; Seidman, A. D.; Theodoulou, M.; Moynahan, M. E.; Currie, V.; Moasser, M.; Sklarin, N.; Gilewski, T.; D'Andrea, G.; Salvaggio, R.; more...
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • 5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study
    Journal Article

    Hudis, C.; Fornier, M.; Riccio, L.; Lebwohl, D.; Crown, J.; Gilewski, T.; Surbone, A.; Currie, V.; Seidman, A.; Reichman, B.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save